|Articles|August 27, 2015

Admedus Adopts the Medidata Clinical Cloud® in Vaccine Study

Author(s)Applied Clinical Trials Editorial Staff

Admedus adopts the Medidata Clinical Cloud® to bring greater speed and efficiency to it’s genital herpes therapeutic vaccine study.

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, announced that Australian-based specialist healthcare company Admedus is using its Medidata Clinical Cloud^® platform in its clinical development of a therapeutic vaccine for genital herpes.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Admedus Adopts the Medidata Clinical Cloud® in Vaccine Study

Related Content

Two New Partnerships Aim to Expand Patient Access to Clinical Trials Through Community-Based Research

Where Capability Gaps Hide When Scientific Intent Doesn't Translate Into Operations

ACT Brief: Product Development Assumptions, Portfolio-Level Recruitment Infrastructure, and Risk-Based Quality Integration

From Study-by-Study to Portfolio Recruitment: Q&A with Gaynor Anders, Trialbee

Why Execution Strategy Begins at the Business Decision, Not Study Startup

Trending on Applied Clinical Trials Online

From Study-by-Study to Portfolio Recruitment: Q&A with Gaynor Anders, Trialbee

ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN

Two New Partnerships Aim to Expand Patient Access to Clinical Trials Through Community-Based Research

ACT Brief: Sponsor Accountability in Outsourcing, Biomarker Strategy in Precision Oncology, and Novel Sciatica Therapy

Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology